SIC 2834 – Pharmaceutical Preparations
Valuation | |
---|---|
Market Cap ($M) | 6.25 |
Enterprise Value ($M) | 10.06 |
Book Value ($M) | 24.45 |
Book Value / Share | 4.11 |
Price / Book | 0.26 |
NCAV ($M) | -4.92 |
NCAV / Share | -0.83 |
Price / NCAV | -1.27 |
Profitability (mra) | |
---|---|
Return on Invested Capital (ROIC) | -0.46 |
Return on Assets (ROA) | -0.38 |
Return on Equity (ROE) | -0.43 |
Liquidity (mrq) | |
---|---|
Quick Ratio | 1.72 |
Current Ratio | 1.85 |
Balance Sheet (mrq) ($M) | |
---|---|
Current Assets | 2.47 |
Assets | 31.84 |
Liabilities | 7.39 |
Debt | n/a |
Equity | n/a |
Income Statement (mra) ($M) | |
---|---|
Revenue | 0.12 |
Operating Income | -12.92 |
Net Income | -13.77 |
Earnings Per Share Basic And Diluted | n/a |
Cash Flow Statement (mra) ($M) | |
---|---|
Cash From Operations | -4.69 |
Cash from Investing | -0.10 |
Cash from Financing | 4.92 |
(click for more detail) |
File Date | Form | Activist 13D/G Investors | Ownership (%) |
Change (%) |
---|---|---|---|---|
13D/A | Amarillo Biosciences Inc | 50.84 | ||
13D/A | Ainos Inc | 62.05 | -95.80 |
Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
---|---|---|---|---|
(click for more detail) |
Date | Insider Trades | Code | Shares | Value |
---|---|---|---|---|
(click for more detail) |
File Date | Form | SEC Filings |
---|---|---|
U.S. Securities and Exchange Commission Washington, D.C. 20549 FORM 10-K | ||
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q/A | ||
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q | ||
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q | ||
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q | ||
(click for more detail) |
Short Volume | |||
---|---|---|---|
Market Date | Short Volume | Total Volume | Short Volume Ratio |
394 | 19,503 | 2.02 | |
710 | 1,009 | 70.37 | |
2,046 | 5,835 | 35.06 | |
973 | 4,053 | 24.01 | |
(click for more detail) |
Similar Companies | |
---|---|
ADVM – Adverum Biotechnologies, Inc. | AEZS – Aeterna Zentaris Inc. |
AGEN – Agenus Inc. | AKAN – Akanda Corp. |
AKBA – Akebia Therapeutics, Inc. |
Financial data and stock pages provided by
Fintel.io